Evidence map›Paper›PMID 22767269›Full record

ArticleNanoscale2012

In vivo demonstration of enhanced radiotherapy using rare earth doped titania nanoparticles.

Helen E Townley, Jeewon Kim, Peter J Dobson

Abstract read
In one paragraph

Article in Nanoscale, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. A GdWMolecules (Basel, Switzerland) · 2021
    Article
  5. Review
  6. Advances in Gold Nanoparticle-Based Combined Cancer Therapy.Nanomaterials (Basel, Switzerland) · 2020
    Review
  7. Article
  8. TiOInternational journal of molecular sciences · 2020
    Article
  9. Article
  10. Carbon-Doped TiOInternational journal of molecular sciences · 2019
    Article
  11. Article
  12. Nanoparticles to mediate X-ray-induced photodynamic therapy and Cherenkov radiation photodynamic therapy.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology · 2019
    Review
  13. Article
  14. Article
  15. Titanium Dioxide Nanoparticles as Radiosensitisers: AnInternational journal of medical sciences · 2017
    Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Helen E TownleyDepartment of Engineering Science, Oxford University, Oxford, UK. Helen.Townley@eng.ox.ac.uk
Jeewon Kim
Peter J Dobson

Funding

Translational Oncology Research Program (Project-005)P30CA124435 · NCI · STANFORD UNIVERSITY · PI Melinda L. Telli · 2007 to 2026
$71.4M
NCI NIH HHS P30 CA124435
6 · The paper itself

Abstract

Radiation therapy is often limited by damage to healthy tissue and associated side-effects; restricting radiation to ineffective doses. Preferential incorporation of materials into tumour tissue can enhance the effect of radiation. Titania has precedent for use in photodynamic therapy (PDT), generating reactive oxygen species (ROS) upon photoexcitation, but is limited by the penetration depth of UV light. Optimization of a nanomaterial for interaction with X-rays could be used for deep tumour treatment. As such, titania nanoparticles were doped with gadolinium to optimize the localized energy absorption from a conventional medical X-ray, and further optimized by the addition of other rare earth (RE) elements. These elements were selected due to their large X-ray photon interaction cross-section, and potential for integration into the titania crystal structure. Specific activation of the nanoparticles by X-ray can result in generation of ROS leading to cell death in a tumour-localized manner. We show here that intratumoural injection of RE doped titania nanoparticles can enhance the efficacy of radiotherapy in vivo.

Indexed as

AnimalsApoptosisCell Line, TumorGadoliniumHep G2 CellsHumansMetal NanoparticlesMetals, Rare EarthMiceNeoplasmsReactive Oxygen SpeciesTitaniumTransplantation, HeterologousUltraviolet RaysX-RaysGadoliniumMetals, Rare EarthReactive Oxygen SpeciesTitaniumtitanium dioxide

Identifiers

PMID22767269
PMCPMC5520801

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.